Stock search

Ticker or company name

Boston Scientific

BSX · NYSE · Health Care

$43,69Down −0,65 (−1,47%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$64,3 bn
Div. yield
—
Year to date
−53,5%
52 weeks: $39,57$105,65

Ratio score

83/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

6 ✓ · 3 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM18,462,225,1
Forward P/E14,0—16,2
PEG0,7—2,2
P/S3,15,72,2
EV/EBITDA15,632,817,3
P/FCF19,3—19,5
P/B2,54,23,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 37 analysts

Buy
24
Hold
12
Sell
1

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20260,720,73Up +0,9%
Q2 20260,840,86Up +2,9%
Q1 20260,790,80Up +0,7%
Q4 20250,790,80Up +1,6%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue5,14 bn5,44 bn5,20 bn5,29 bn5,07 bn5,06 bn4,66 bn4,56 bn4,21 bn4,12 bn3,86 bn3,73 bn
EPS0,400,610,900,450,510,530,450,380,320,220,330,34
Margin11,3%16,6%25,7%12,7%14,9%15,7%14,4%12,3%11,1%7,8%12,8%13,5%
FCF868 m1,28 bn171 m1,01 bn1,16 bn1,13 bn354 m1,18 bn823 m658 m−15,0 m690 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $10,0 m (5 people), sales $16,8 m.

NameAmountSharesPrice
morano susan e25 Aug 2026 · open-market purchase$100 4082 040$49,22
habiger david c5 Aug 2026 · open-market purchase$99 9372 100$47,59
habiger david c4 Aug 2026 · open-market purchase$6 802140$48,59
mahoney michael f3 Aug 2026 · open-market purchase$9,00 m186 240$48,33
habiger david c3 Aug 2026 · open-market purchase$50 0841 042$48,07
ludwig edward j31 Jul 2026 · open-market purchase$227 4005 000$45,48
pegus cheryl20 May 2026 · open-market purchase$99 9871 770$56,49
habiger david c20 May 2026 · open-market purchase$125 8192 250$55,92
ludwig edward j20 May 2026 · open-market purchase$202 9143 580$56,68
habiger david c19 May 2026 · open-market purchase$125 2792 200$56,95
mahoney michael f2 Feb 2026 · sale$14,9 m159 701$93,49
mahoney michael f2 Feb 2026 · sale$112 8681 200$94,06
butcher arthur c1 Dec 2025 · sale$1,76 m17 313$101,55

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
19 May 1992

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
CAHCardinal Health$283,85no score35,7——
EWEdwards Lifesciences$107,1156would watch60,3+13,4%15,2%
CORCencora$356,9483would consider19,7+5,1%0,8%
BDXBecton Dickinson$216,4738would not consider51,8−2,6%4,5%
IDXXIdexx Laboratories$700,6583would consider47,2+11,9%25,4%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.